Unlock instant, AI-driven research and patent intelligence for your innovation.

Synergistic prodrug derivatives of ubenimex derivatives and compounds with antitumor activity, preparation methods and applications thereof

A technology with anti-tumor activity and ubenimex, which is applied in the preparation of organic compounds, urea derivatives, sugar derivatives, etc., can solve the problems of poor fat solubility, low bioavailability, and large toxic and side effects, and achieve Effects of prolonging residence time, increasing bioavailability, and improving pharmacokinetic properties

Active Publication Date: 2021-03-23
江西润泽药业有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, clinical studies have found that cytarabine has a series of disadvantages: poor fat solubility, low bioavailability, large toxic and side effects, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synergistic prodrug derivatives of ubenimex derivatives and compounds with antitumor activity, preparation methods and applications thereof
  • Synergistic prodrug derivatives of ubenimex derivatives and compounds with antitumor activity, preparation methods and applications thereof
  • Synergistic prodrug derivatives of ubenimex derivatives and compounds with antitumor activity, preparation methods and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0054] In a specific embodiment, the preparation method of the synergistic prodrug derivative of the ubenimex derivative and the compound with anti-tumor activity comprises: putting 5 mmol of the compound with anti-tumor activity into a reaction bottle, adding 20 ml Pyridine was dissolved completely, and then 0.65 g of activated carbon was added, and 0.5 g of triphosgene was slowly added in an ice bath, and the reaction was continued for 1 hour under an ice bath, the phosgene was drawn out, and then poured into N 2 , carried out three times; under ice bath, slowly added 5 mmol of the ubenimex derivative, and then reacted at room temperature for 12 hours; filtered activated carbon, extracted with ethyl acetate, washed 3 times with 6mol / L hydrochloric acid solution, and then washed with saturated brine 3 times, dried over anhydrous sodium sulfate, distilled off the ethyl acetate until solid precipitation stopped, put it in the refrigerator for crystallization, and filtered to obt...

preparation example 1

[0065] Put 5mmol pentafluorouracil (0.65g) in a reaction flask, add 20ml of pyridine to dissolve it completely, then add 0.65g of activated carbon, slowly add 0.5g of triphosgene under ice bath, continue to react under ice bath for 1 hour, draw out Phosgene, rushed into N 2 , for three times. Under ice-cooling, 5 mmol of ubenimex (1.7 g) was slowly added, followed by reaction at room temperature for 12 hours. Activated carbon was filtered, extracted with ethyl acetate, washed three times with 6 mol / L hydrochloric acid solution, washed three times with saturated brine, and dried over anhydrous sodium sulfate. Ethyl acetate was distilled off until the precipitation of solids ceased, put into the refrigerator for crystallization, and filtered to obtain a white product, which was compound 5FU-Bestatin, a white solid, yield: 36.7%, melting point=165-167°C. MS-ESI: [M-1]=463.6; [M-1+Na]=485.8. Its proton nuclear magnetic resonance spectrum data are as follows:

[0066] 300MHz 1...

preparation example 2-13

[0068] Synergistic prodrug derivatives were prepared according to a method similar to that of Preparation Example 1, the difference being that the compounds with antitumor activity and ubenimex derivatives used were listed in the following table 1 respectively to obtain synergistic prodrug derivatives I -1 to I-12, their structural formulas are shown in Table 1 below.

[0069] Table 1

[0070]

[0071]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicinal chemistry, and discloses ubenimex derivatives, synergistic prodrug derivatives having an antitumor active compound as well as a preparation method and application of the synergistic prodrug derivatives. The ubenimex derivatives and the synergistic prodrug derivatives having the antitumor active compound have a chemical structure represented by a formula (I) shown in the description, wherein R is a compound residue having antitumor activity, R<1> is a C1-C5 alkyl, a halogen or a C1-C5 alkoxy, and R<2> and R<3> are individually a C1-C5 alkyl or a halogen-substituted C1-C5 alkyl. The synergistic prodrug derivatives provided by the invention are suitable for treating various tumors.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a synergistic prodrug derivative of an ubenimex derivative and a compound with antitumor activity, a preparation method and application thereof. Background technique [0002] Ubenimex (Bestatin) is a compound of dipeptide structure found in the culture fluid of Streptomycesolivoreticuli, which was listed in Japan in 1987 as an immune enhancer for the treatment of leukemia; Ubenimex The company was listed in China in 1998. Ubenimex can inhibit the activity of APN (IC50 at 2.5-16.9μM), and can block the effect of tumor stem cells, but it has almost no ability to inhibit the proliferation of tumor cells, so Ubenimex is used in combination with other cell-based anti-tumor drugs will greatly improve its efficacy. Studies in the literature have shown that in mice liver cancer xenograft tumor experiments, the combined use of Ubenimex and pentafluorouracil is significantly better tha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D239/557C07D401/04C07H19/09C07H1/00C07C275/26C07C273/18A61P35/00A61K31/65A61K31/7068A61K31/454A61K31/513
Inventor 邹明明廖年生胡贤德徐满
Owner 江西润泽药业有限公司